EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Prospective study to evaluate radioactive iodine of 20 mCi vs 10–15 mCi in Graves’ disease

Wasit Kanokwongnuwat, Nawarat Penpong

BMC Endocrine Disorders · 2024

DOI: 10.1186/s12902-024-01588-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Wasit Kanokwongnuwat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology, Phrapokklao Hospital, No 38, Leab Neon Road, Mueang, Chanthaburi, 22000, Thailand. wasit.k@chu…. Hauptthemen laut MEDLINE: Graves Disease, Iodine Radioisotopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Phrapokklao Medical Education Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess whether increasing radioactive iodine dose can increase treatment efficacy in Graves’ disease.

Methods

A prospective study was conducted, including 106 patients receiving 20 mCi (740 MBq) radioactive iodine (RAI), compared with a retrospective data, including 113 patients receiving 10–15 mCi (370–555 MBq) RAI. Remission and failure rates were evaluated at 6 months post-RAI. Statistical analysis was performed using logistic regression and Kaplan–Meier curves.

Results

Patients receiving 20 mCi RAI demonstrated a significantly higher remission rate compared to the 10–15 mCi group (82.1% vs 66.4%, p = 0.009). Median time to remission was shorter in the 20 mCI group (3 vs 4 months, p = 0.002). Hypothyroidism at 6 months was more prevalent in the 20 mCi group (67% vs 53%, p = 0.03). Larger thyroid size (> 60 g) was associated with treatment failure ( p = 0.02).

Conclusions

Higher dosage (20 mCi) RAI showed superior efficacy in achieving remission compared to lower dosages (10–15 mCi) in Graves’ disease treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseIodine RadioisotopesHumansFemaleMaleProspective StudiesMiddle AgedAdultRetrospective StudiesFollow-Up StudiesTreatment OutcomeAgedPrognosis

Stichwörter der Autor:innen

Graves' diseaseHyperthyroidismIncreasing doseRadioactive iodineRemissionTreatment efficacy

Substanzen

Iodine Radioisotopes

Autor:innen und Institutionen

  • Division of Nuclear Medicine, Department of Radiology, Phrapokklao Hospital, No 38, Leab Neon Road, Mueang, Chanthaburi, 22000, Thailand. wasit.k@chula.ac.th.
  • Division of Endocrinology, Department of Internal Medicine, Phrapokklao Hospital, No 38, Leab Neon Road, Mueang, Chanthaburi, 22000, Thailand.

Förderung

  • Phrapokklao Medical Education Center

Zitieren

APA

Kanokwongnuwat, W., & Penpong, N. (2024). Prospective study to evaluate radioactive iodine of 20 mCi vs 10–15 mCi in Graves’ disease. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01588-3

Vancouver

Kanokwongnuwat W, Penpong N. Prospective study to evaluate radioactive iodine of 20 mCi vs 10–15 mCi in Graves’ disease. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01588-3

BibTeX
@article{Kanokwongnuwat2024,
  author = {Kanokwongnuwat, Wasit and Penpong, Nawarat},
  title = {Prospective study to evaluate radioactive iodine of 20 mCi vs 10–15 mCi in Graves’ disease},
  journal = {BMC Endocrine Disorders},
  year = {2024},
  doi = {10.1186/s12902-024-01588-3}
}
Kostenlos starten →